Bariatric surgery induces a new gastric mucosa phenotype with increased functional glucagon-like peptide-1 expressing cells

Nat Commun. 2021 Jan 4;12(1):110. doi: 10.1038/s41467-020-20301-1.

Abstract

Glucagon-Like Peptide-1 (GLP-1) undergoes rapid inactivation by dipeptidyl peptidase-4 (DPP4) suggesting that target receptors may be activated by locally produced GLP-1. Here we describe GLP-1 positive cells in the rat and human stomach and found these cells co-expressing ghrelin or somatostatin and able to secrete active GLP-1 in the rats. In lean rats, a gastric load of glucose induces a rapid and parallel rise in GLP-1 levels in both the gastric and the portal veins. This rise in portal GLP-1 levels was abrogated in HFD obese rats but restored after vertical sleeve gastrectomy (VSG) surgery. Finally, obese rats and individuals operated on Roux-en-Y gastric bypass and SG display a new gastric mucosa phenotype with hyperplasia of the mucus neck cells concomitant with increased density of GLP-1 positive cells. This report brings to light the contribution of gastric GLP-1 expressing cells that undergo plasticity changes after bariatric surgeries, to circulating GLP-1 levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • Adult
  • Amino Acid Sequence
  • Animals
  • Bariatric Surgery*
  • Diet, High-Fat
  • Female
  • Gastric Mucosa / metabolism*
  • Gastric Mucosa / pathology*
  • Glucagon-Like Peptide 1 / chemistry
  • Glucagon-Like Peptide 1 / metabolism*
  • Glucose / metabolism
  • Humans
  • Male
  • Middle Aged
  • Obesity / pathology
  • Phenotype
  • Rats
  • Rats, Wistar

Substances

  • Glucagon-Like Peptide 1
  • Glucose
  • 1-Methyl-3-isobutylxanthine